Skip to Content

Industry Insights .

Search By Author:
5 / 23 / 2024

Compliant Speaker Programs: How Life Sciences Companies Can Mitigate Risk

By
Ann Brandt
Pharmaceutical, medical device, and biotechnology companies (collectively life sciences companies or “LSCs”) utilize outside ‘experts’ (“Healthcare Professionals” and “Key Opinion Leaders”, collectively “HCPs/KOLs”) to provide a wide variety of...
10 / 10 / 2023

Determining the Fair Market Value of HCP Compensation: Five Considerations When Engaging Speakers, Consultants, and Researchers Outside the U.S.

By
Ann Brandt
In many countries and regions of the world, access to valid, reliable, and comprehensive healthcare professional (“HCP”) compensation data can be a challenging task. Notwithstanding, in countries outside of...